The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation

C.T. Collins, R.A. Gibson, M. Makrides, A.J. Mcphee, T.R. Sullivan, P.G. Davis, M. Thio, Karen Simmer, V.S. Rajadurai, P. Ryan, S. Morris, M. Stark, J. Travadi, I. Wright, K. Tan, J. Holberton, G. Opie, I. Callander, J. Stack, D. SheinS. Bellhouse, S. Bolisetty, K. Lui, H. Liley, M. Berry, D. Harris, M.C. Chua, P. Agarwal

    Research output: Contribution to journalArticlepeer-review

    27 Citations (Scopus)

    Search results